missing translation for 'onlineSavingsMsg'
Learn More

PF 04671536 hydrochloride

Potent and selective PDE8B/8A inhibitor

£94.00 - £343.00

Specifications

Chemical Name or Material 5-Methyl-3-[[(2R)-4-(2-thiazolylmethyl)-2-morpholinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-7-amine hydrochloride
CAS 1305116-67-9
Assay Percent Range >98%
Molecular Formula C14H18N8OS.HCl
Formula Weight Observed MW: 382.87
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18777108
View Documents
Tocris Bioscience
6024/25
25 mg
£343.00
25mg
Please to purchase this item. Need a web account? Register with us today!
18766378
View Documents
Tocris Bioscience
6024/5
5 mg
£94.00
5mg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Potent and selective PDE8B/8A inhibitor ( IC50 values are 1.3 and 1.9 nM, respectively). Exhibits selectivity for PDE8A/B over other PDEs (IC50 values are >10 μM) and a range of other targets. Increases glucose-dependent insulin secretion from human pacreatic islet cells. Orally bioavailable.
Specifications

Specifications

5-Methyl-3-[[(2R)-4-(2-thiazolylmethyl)-2-morpholinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-7-amine hydrochloride
>98%
Observed MW: 382.87
1305116-67-9
C14H18N8OS.HCl
Videos
Safety and Handling

Safety and Handling

Recommended Storage : Desiccate at Room Temperature

SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.